These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1164465)

  • 21. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
    Wahren B; Edsmyr F; Zimmerman R
    Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
    Korsten CB; Persijn JP; Renaud J
    Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
    Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
    Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
    Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 28. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
    Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
    Alsabti EA; Saffo MH
    Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
    Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The carcinoembryonic antigen test in urologic cancer.
    Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary carcinoembryonic like antigen levels in patients with urinary tract reconstruction using bowels.
    Oshiumi Y; Yagi H; Nishitani H; Nakayama C; Kamoi I; Matsuura K; Momose S
    Radioisotopes; 1978 Aug; 27(8):456-9. PubMed ID: 734164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
    Zimmerman R; Wahren B; Edsmyr F
    Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
    Yang SC
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoembryonic antigen in the urine of patients with urothelial carcinoma.
    Hall RR; Laurence DJ; Darcy D; Stevens U; James R; Roberts S; Munro Neville A
    Br Med J; 1972 Sep; 3(5827):609-11. PubMed ID: 5071696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder cancer detection and surveillance: carcinoembryonic antigen as a monitor of neoplastic transformation.
    Boileau M; Swartz D; Schmidt K; Schmidt W
    J Surg Oncol; 1987 Jun; 35(2):120-3. PubMed ID: 3586682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carcinoembryonic antigen (CEA) in tumor tissue, serum and urine in cases with tumors of the urinary tract. A study by immunohistochemistry and radioimmunoassay].
    Kanokogi M
    Nihon Hinyokika Gakkai Zasshi; 1984 Oct; 75(10):1558-71. PubMed ID: 6396428
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
    Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
    J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.